Evaluation of the use of drug therapy leaflets for diabetic sick days

Evaluation of the use of drug therapy leaflets for diabetic sick days - Evaluation of the use of drug therapy leaflets for diabetic sick days

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000049562

Enrollment

160

Registered

2022-12-20

Start date

2022-12-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Guidance to patients using a leaflet for pharmacotherapy during diabetic sick days that was originally created

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients undergoing drug therapy for diabetes

Exclusion criteria

Exclusion criteria: Patients with memory impairment or dementia. Patients who requested to withdraw consent.

Design outcomes

Primary

Measure	Time frame
The primary outcome measure was the number and proportion of patients who understood how to deal with antidiabetic drugs during sick days.	—

Countries

Japan

Contacts

Public ContactGaku Inoue

Kitasato Institute Hospital Department of Pharmacy

inoueg@pharm.kitasato-u.ac.jp03-3444-6161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026